Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20100314003566N9Phase 3Completed
Phase 3 trial of fluorouracil in Hypertrophic Scar (HS), keloid and other disorders of skin and subcutaneous tissue in diseases classified elsewhere (L99) (2 arms), sponsored by Tabriz University of Medical Sciences. Started Jan 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20100314003566N9.